ArticleCureus2025
Corneal Confocal Microscopy in Postural Orthostatic Tachycardia Syndrome (POTS) as a Diagnostic Tool for Small Fiber Neuropathy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePostural orthostatic tachycardia syndrome (POTS) is a debilitating condition characterized by autonomic dysregulation. Patients with this disorder may experience orthostatic intolerance, palpitations, fatigue, and a wide variety of other symptoms. The neuropathic symptoms of POTS may be caused by small fiber neuropathy (SFN), which is currently diagnosed using skin nerve biopsy. Corneal confocal microscopy (CCM) is an imaging modality that allows visualization of the corneal nerve layer. Our study aimed to determine whether CCM could detect differences in small nerve fiber parameters between POTS patients with and without signs or symptoms of SFN. MATERIALS AND
methodsCCM was performed on nine patients, along with a neurological examination. Participants were also asked about neuropathic symptoms by a researcher. Based on examination findings and/or reported symptoms, patients were categorized into SFN+ and SFN- groups for comparison. A chart review was conducted to gather demographic data, medications, autonomic testing results, and medical history, including common POTS comorbidities.
resultsComparison of nerve fiber parameters using CCM did not reveal a statistically significant difference between the groups. However, valuable insights were gained regarding the logistics of conducting this type of study in POTS patients, including adapting to challenges and improving coordination between the neurology and ophthalmology departments.
conclusionsCCM may one day replace skin nerve biopsy as a diagnostic tool for SFN in POTS patients. Although this preliminary analysis did not demonstrate significant findings, likely due to the small sample size, we believe CCM may still have a role in POTS research and could eventually become a diagnostic tool used in autonomic clinics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.